Thousand Oaks-based biotech giant Amgen announced this morning that it has appointed Jonathan M. Peacock as Chief Financial Officer. Peacock replaces Michael A. Kelly, who has been acting CFO since May. According to Amgen, Peacock joins from Novartis Pharmaceuticals AG, where he was CFO and Administrative Officer since 2005, and also has served at McKinsey and COmpany and Price Waterhouse. Peacock reports to CEO and Chairman Kevin W. Sharer.